Tropic is a pioneering tropical seeds company dedicated to the development of healthier, more robust, high-performing varieties of tropical crops. The company’s current core crop portfolio focusses on banana and rice, which together provide a source of livelihood to billions of people worldwide. Tropic utilises its proprietary GEiGS® platform and other cutting-edge gene editing technologies to develop improved crops with increased disease resistance, higher yields, and environmentally sustainable traits. By harnessing the power of advanced genetic engineering, Tropic is committed to addressing global agricultural challenges and providing innovative solutions that benefit farmers, consumers, and the environment.
Tropic
- Agriculture
- Norwich, United Kingdom
- £80m
- tropic.bio
- Update Information
More venture news
- 12 Mar 2026

TropicTropic secures £80m Series C led by Forbion and Corteva for gene-edited tropical crop varieties
Series CAgriculture - 9 Mar 2026


Cytotrait secures a £3m seed round led by Northern Gritstone to develop novel genetic traits for crops
EquityAgriculture - 3 Mar 2026

ALORAALORA secures funding led by the Neglected Climate Opportunities Fund to create crops that increase yield under heat stress
EquityAgriculture
